BT02
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for BT02, covering 2024-12-27 to 2025-09-17. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1, Phase 2]